Inventor

SPRINGER CAROLINE

GB9 patents

⚠️ This page may combine multiple inventors who share the name “SPRINGER CAROLINE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

THE INSTITUTE OF CANCER RES ROYAL CANCER HOSPITAL

6 patents

US10995088B2May 4, 2021

Methylamine derivatives as lysysl oxidase inhibitors for the treatment of cancer

THE INSTITUTE OF CANCER RES ROYAL CANCER HOSPITAL2 citations69

US10807974B2Oct 20, 2020

Methylamine derivatives as lysysl oxidase inhibitors for the treatment of cancer

THE INSTITUTE OF CANCER RES ROYAL CANCER HOSPITAL2 citations69

US11608330B2Mar 21, 2023

Methylamine derivatives as lysysl oxidase inhibitors for the treatment of cancer

THE INSTITUTE OF CANCER RES ROYAL CANCER HOSPITAL0 citations59

US12060360B2Aug 13, 2024

Lysyl oxidase inhibitors

THE INSTITUTE OF CANCER RES ROYAL CANCER HOSPITAL0 citations58

US11325915B2May 10, 2022

Lysyl oxidase inhibitors

THE INSTITUTE OF CANCER RES ROYAL CANCER HOSPITAL1 citations58

US12018029B2Jun 25, 2024

Hexahydropyrrolo[3,4-c]pyrrole derivatives useful as LOX inhibitors

THE INSTITUTE OF CANCER RES ROYAL CANCER HOSPITAL0 citations45

CANCER RES TECH LTD

1 patent

US9439893B2Sep 13, 2016

1-(5-tert-butyl-2-phenyl-2H-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,3-dihydro-1H-imidazo[4,5-B]pyridin-7-yloxy)-phenyl]-urea and related compounds and their use in therapy

CANCER RES TECH LTD4 citations83

CANCER REC TECH LTD

1 patent

US9120789B2Sep 1, 2015

1-(5-tert-butyl-2-phenyl-2H-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-7-yloxy)-phenyl]-urea and related compounds and their use in therapy

CANCER REC TECH LTD7 citations83

SPRINGER CAROLINE

1 patent

US8815896B2Aug 26, 2014

1-(5-tert-butyl-2-phenyl-2H-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,3-dihydro-1H-imidazo[4,5-B]pyridin-7-yloxy)-phenyl]-urea and related compounds and their use in therapy

SPRINGER CAROLINE7 citations79